Lentivirus transfection reagent is designed to enhance delivery of packaging and transfer vector DNA to suspension and adherent HEK 293 cell types in order to increase production of adeno-associated virus (AAV) and lentivirus.
This report contains market size and forecasts of Lentivirus and AAV Transfection Reagent in global, including the following market information:
Global Lentivirus and AAV Transfection Reagent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lentivirus and AAV Transfection Reagent Market Sales, 2017-2022, 2023-2028, (K Unit)
Global top five Lentivirus and AAV Transfection Reagent companies in 2021 (%)
The global Lentivirus and AAV Transfection Reagent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
AAV Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lentivirus and AAV Transfection Reagent include Mirus Bio, Thermo Fisher Scientific, Polyplus-transfection, Takara Bio, GeneMedi, SignaGen Laboratories, Roche, Invitrogen and System Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lentivirus and AAV Transfection Reagent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lentivirus and AAV Transfection Reagent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Unit)
Global Lentivirus and AAV Transfection Reagent Market Segment Percentages, by Type, 2021 (%)
AAV
Lentivirus
Complex
Global Lentivirus and AAV Transfection Reagent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Unit)
Global Lentivirus and AAV Transfection Reagent Market Segment Percentages, by Application, 2021 (%)
Laboratory
Hospital
Global Lentivirus and AAV Transfection Reagent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Unit)
Global Lentivirus and AAV Transfection Reagent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lentivirus and AAV Transfection Reagent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lentivirus and AAV Transfection Reagent revenues share in global market, 2021 (%)
Key companies Lentivirus and AAV Transfection Reagent sales in global market, 2017-2022 (Estimated), (K Unit)
Key companies Lentivirus and AAV Transfection Reagent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mirus Bio
Thermo Fisher Scientific
Polyplus-transfection
Takara Bio
GeneMedi
SignaGen Laboratories
Roche
Invitrogen
System Bioscience
WZ Biosciences
Inovogen Tech